SCHEMBL25802449

SCHEMBL25802449

O=S(=O)(c1ccc(Br)cc1)c1ccc(O)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.45
HSD11B1 P28845 2/20 0.45
GAA P10253 3/20 0.44
GFER P55789 1/20 0.44
AKR1B1 P15121 2/20 0.42
HSD17B2 P37059 1/20 0.42
CNR1 P21554 1/20 0.41
PKM P14618 2/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.39
KAT6A Q92794 1/20 0.38
CA2 P00918 2/20 0.38
CA1 P00915 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
PIK3CA P42336 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10967694 0.83 COMT (0.49) POLBHSD11B1GAAGFERCNR1
SCHEMBL25020313 0.80 CCR2 (0.51) POLBHSD11B1AKR1B1CNR1ALDH1A1
SCHEMBL25873556 0.80 MEN1 (0.46) HSD11B1GAAAKR1B1CNR1PKM
SCHEMBL28793992 0.80 CA2 (0.42) POLBHSD11B1GAAGFERCNR1
SCHEMBL1990245 0.79 LMNA (0.55) HSD11B1AKR1B1PKMLMNATP53
SCHEMBL2350373 0.76 AKR1B1 (0.51) POLBHSD11B1GAAGFERAKR1B1
SCHEMBL7938049 0.76 ALOX15 (0.62) GAAHSD17B2PKMLMNAALOX15
SCHEMBL24311147 0.73 FEN1 (0.44) HSD11B1HSD17B2CNR1PKMLMNA
SCHEMBL2909345 0.73 PKM (0.53) HSD11B1GAAAKR1B1CNR1PKM
SCHEMBL13758572 0.72 LMNA (0.44) POLBGAAGFERLMNAKAT6A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752496-B1 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION GILEAD SCIENCES INC (US) 2023-07-05 EP disclosed